English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

BackgroundCoronary artery disease (CAD) is one of the major causes of death worldwide. There is a direct relationship between increased levels of blood cholesterol, triglycerides (TG), low density lipoproteins (LDL), high density lipoproteins (HDL), nitric oxide (NO), and high sensitivity C-reactive protein (hs-CRP) and the CAD. Walnut may reduce these factors and consequently decrease the risk of CAD.ObjectivesThe aim of this study was to evaluate the effect of walnut consumption on TG, LDL, cholesterol, HDL, NO, and hs-CRP in patients with CAD and healthy people.Patients and MethodsIn this randomized crossover clinical trial, 70 patients with CAD were divided into two groups: case and control groups. The patients were given 40 g walnuts daily for 4 weeks. After 4 weeks, the TG, LDL, cholesterol, HDL, NO and hs-CRP levels were measured. The experiment was also carried out on healthy people (3 groups) with normal range of lipid. The LDL, HDL, cholesterol, and hs-CRP levels were measured using commercially available kits. The nitric oxide level was measured using the Griess reaction method.ResultsThe cholesterol and LDL levels decreased significantly from 202.43 to 187.46 and 123.80 to 108.63 mmol/L (7.9% and 13.9 %), respectively in healthy subjects after the treatment (P < 0.01). In the experimental group, there was no significant difference in cholesterol (P = 0.110) and LDL levels (P = 0.176) before and after the treatment. Moreover, no significant difference was observed in other parameters between the two groups.ConclusionsThe walnut consumption did not affect cholesterol levels in patients with CAD; however, it might be administered as an agent for reducing the cholesterol, which is one of the risk factors associated with CAD

Effect of Walnut Consumption on Serum Lipid Profiles, High-Sensitivity C-Reactive Protein and Nitric Oxide in Patients With Coronary Artery Disease